1. Home
  2. OVID vs FCO Comparison

OVID vs FCO Comparison

Compare OVID & FCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • FCO
  • Stock Information
  • Founded
  • OVID 2014
  • FCO 1991
  • Country
  • OVID United States
  • FCO United Kingdom
  • Employees
  • OVID N/A
  • FCO N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • FCO Investment Managers
  • Sector
  • OVID Health Care
  • FCO Finance
  • Exchange
  • OVID Nasdaq
  • FCO Nasdaq
  • Market Cap
  • OVID 85.2M
  • FCO 81.4M
  • IPO Year
  • OVID 2017
  • FCO N/A
  • Fundamental
  • Price
  • OVID $1.06
  • FCO $5.97
  • Analyst Decision
  • OVID Strong Buy
  • FCO
  • Analyst Count
  • OVID 5
  • FCO 0
  • Target Price
  • OVID $4.04
  • FCO N/A
  • AVG Volume (30 Days)
  • OVID 216.9K
  • FCO 100.1K
  • Earning Date
  • OVID 11-12-2024
  • FCO 01-01-0001
  • Dividend Yield
  • OVID N/A
  • FCO 14.96%
  • EPS Growth
  • OVID N/A
  • FCO N/A
  • EPS
  • OVID N/A
  • FCO 0.43
  • Revenue
  • OVID $631,695.00
  • FCO N/A
  • Revenue This Year
  • OVID $21.51
  • FCO N/A
  • Revenue Next Year
  • OVID $7,300.79
  • FCO N/A
  • P/E Ratio
  • OVID N/A
  • FCO $12.30
  • Revenue Growth
  • OVID 113.21
  • FCO N/A
  • 52 Week Low
  • OVID $0.68
  • FCO $4.73
  • 52 Week High
  • OVID $4.10
  • FCO $6.63
  • Technical
  • Relative Strength Index (RSI)
  • OVID 37.15
  • FCO 48.57
  • Support Level
  • OVID $1.11
  • FCO $5.96
  • Resistance Level
  • OVID $1.47
  • FCO $6.16
  • Average True Range (ATR)
  • OVID 0.11
  • FCO 0.10
  • MACD
  • OVID -0.02
  • FCO -0.00
  • Stochastic Oscillator
  • OVID 6.82
  • FCO 43.18

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

About FCO abrdn Global Income Fund Inc.

abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets, and Sub-Investment Grade Developing Markets.

Share on Social Networks: